Results 321 to 330 of about 4,106,951 (336)

Tumor biomarkers: PSA and beyond

Clinical Chemistry and Laboratory Medicine (CCLM), 2012
Laboratory medicine plays an increasingly important role in the management of cancer patients (1, 2) . In none of the tumors has the advent of biomarkers changed the treatment in a more fundamental way than the introduction of prostate specifi c antigen (PSA) which has virtually transformed the management of prostate cancer.
openaire   +3 more sources

The Correlation Between Systemic Inflammatory Biomarkers, Tumor-Related Factors, and Survival in Glioblastoma Patients: A prognosticators Perspective

Neurology India, 2021
A. Behrooz, A. Syahir
semanticscholar   +1 more source

Cancer Biomarkers: Tumor-Infiltrating T Cells, Programmed Death-Ligand 1, and Tumor Mutation Burden

Cancer Immunotherapy Principles and Practice, 2021
Colt A. Egelston, Weihua Guo, Peter P. Lee   +2 more
semanticscholar   +1 more source

Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment

Molecular Imaging and Biology, 2022
Paniz Siminzar, M. Tohidkia, E. Eppard, Nasim Vahidfar, A. Tarighatnia, Ayuob Aghanejad   +5 more
semanticscholar   +1 more source

Biomarkers in pancreatic neuroendocrine tumors.

Journal of Clinical Oncology, 2012
166 Background: This study was designed to determine the role of Chromogranin A (CGA) and serotonin as prognostic biomarkers in relation with cytoreductive surgery for pancreatic neuroendocrine tumors (PNETs).The role of CGA and serotonin as biomarkers for PNETs is not fully established.
Randall F. Holcombe, Michelle K. Kim, Angela Tatiana Alistar, Erin Moshier, Richard R.P. Warner   +4 more
openaire   +2 more sources

Toward Precision Medicine: A Cancer Molecular Subtyping Nano-Strategy for RNA Biomarkers in Tumor and Urine.

Small, 2016
Cancer is a heterogeneous disease which manifests as different molecular subtypes due to the complex nature of tumor initiation, progression, and metastasis.
K. M. Koo, E. Wee, P. Mainwaring, Yuling Wang, M. Trau   +4 more
semanticscholar   +1 more source

Brain Tumor Biomarkers in Circulation

2016
Molecular pathology of brain tumors. Circulating glioblastoma (GBM) epigenetic biomarkers. Circulating GBM miRNA biomarkers. Serum GBM protein biomarkers. Circulating GBM cells. Circulating endothelial and endothelial progenitor cells.
openaire   +2 more sources

Neuroendocrine Tumors Biomarkers

2018
Massimo Carlini, Francesca Rota, Rosa Lauretta, Marialuisa Appetecchia   +3 more
openaire   +2 more sources

Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis

Journal of Cellular Physiology, 2018
Mohammad Mashreghi, Hassan Azarpara, M. R. Bazaz, Arash Jafari, A. Masoudifar, H. Mirzaei, M. Jaafari   +6 more
semanticscholar   +1 more source

Image-based biomarkers for solid tumor quantification

European Radiology, 2019
P. Savadjiev, Jaron J. R. Chong, A. Dohan, V. Agnus, R. Forghani, C. Reinhold, B. Gallix   +6 more
semanticscholar   +1 more source